Purchase Order SPE2DP25V3776
- Not listed
- The Medical Supply Chain, a defense-focused federal agency, awarded a purchase order to The Maclean Group LLC for naloxone hydrochloride on September 19, 2025, with a ceiling value of $2,010.06 and an ultimate completion date of October 6, 2025. This firm fixed-price contract with no set-aside designation procures a critical opioid antagonist medication essential for emergency response and overdose reversal. The Maclean Group, a service-disabled veteran-owned small business (SDVOSB) based in...
- The U.S. Medical Supply Chain (Defense) awarded a firm fixed-price purchase order to The Maclean Group LLC, a service-disabled veteran-owned small business (SDVOSB) based in Sacramento, California, for the supply of Naloxone Hydrochloride. The contract, valued at $1,005.03, was awarded on September 5, 2025, with an ultimate completion date of September 22, 2025. No set-aside designation was applied to this procurement. The Maclean Group, an ISO 9001:2015 certified medical and pharmaceutical...
- The U.S. Medical Supply Chain (Defense) awarded a $1,005.03 firm fixed-price purchase order to The Maclean Group LLC, a service-disabled veteran-owned small business based in Sacramento, California, for the supply of Naloxone Hydrochloride. The contract, which was not set aside exclusively for veteran-owned businesses despite the vendor's SDVOSB status, was awarded on May 30, 2025, with an ultimate completion date of July 29, 2025. Performance will occur in Sacramento, California. The Maclean...
- The U.S. Department of Defense Medical Supply Chain awarded a $2,010.06 firm fixed-price purchase order to The Maclean Group LLC for naloxone hydrochloride, with an ultimate completion date of September 24, 2025. This contract, issued on September 9, 2025, carries no set-aside designation and specifies performance at The Maclean Group's Sacramento, California location. The Maclean Group is a service-disabled veteran-owned small business (SDVOSB) and ISO 9001:2015 certified pharmaceutical and...
- The U.S. Department of Defense Medical Supply Chain awarded a firm fixed-price purchase order to The Maclean Group LLC on July 22, 2025, for the delivery of Naloxone Hydrochloride with a ceiling value of $7,035.21. The contract is scheduled for completion by August 6, 2025, and performance will take place in Sacramento, California. This award was issued without a set-aside designation. The Maclean Group, a service-disabled veteran-owned small business (SDVOSB) and ISO 9001:2015 certified...
- The U.S. Department of Defense's Medical Supply Chain agency awarded a $1,005.03 firm fixed price purchase order to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Sacramento, California. The award is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose, and has a period of performance through March 13, 2025. The Maclean Group, an ISO 9001:2015 certified medical and pharmaceutical...
- This $3,015.09 firm fixed-price purchase order was awarded to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Jacksonville, Florida. The contract was awarded by the Defense Logistics Agency's Medical Supply Chain Division for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The contract has an ultimate completion date of December 9, 2024. The Maclean Group LLC is an ISO 9001:2015...
- The U.S. Department of Defense's Medical Supply Chain awarded a purchase order to The Maclean Group LLC, a service-disabled veteran-owned small business (SDVOSB) based in Sacramento, California, for the procurement of Naloxone Hydrochloride. The contract, awarded on April 24, 2025, carries a ceiling value of $6,030.18 and is structured as a firm fixed-price purchase order with an ultimate completion date of May 9, 2025. The award utilizes no set-aside designation and will be performed in...
- This is a firm fixed-price purchase order awarded by the Medical Supply Chain division of the Defense agency to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Sacramento, California. The contract is for the delivery of naloxone hydrochloride, with a ceiling value of $1,005.03 and a performance period through May 20, 2025. The Maclean Group holds several significant federal contract vehicles, including a $2.63...
- The U.S. Department of Defense's Medical Supply Chain agency has awarded a firm fixed-price purchase order contract valued at $1,005.03 to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The contract has an ultimate completion date of May 10, 2024. The Maclean Group is an ISO 9001:2015 certified medical and...
The U.S. Medical Supply Chain (Defense) awarded a firm fixed-price purchase order to The Maclean Group LLC for naloxone hydrochloride with a ceiling value of $1,005.03. The award was made on September 29, 2025, with an ultimate completion date of October 14, 2025. This contract carries no set-aside designation, despite the prime contractor being a service-disabled veteran-owned small business (SDVOSB) certified in Sacramento, California. The brief performance window indicates this is likely a discrete purchase order fulfilling immediate medical supply needs rather than an ongoing indefinite delivery vehicle. The Maclean Group LLC brings substantial federal contracting experience to this award as an ISO 9001:2015 certified pharmaceutical and medical wholesale distributor. The vendor maintains multiple federal supply schedule contracts and indefinite delivery vehicles with agencies including the Department of Veterans Affairs, Department of Defense, and Naval Air Systems Command, with cumulative vehicle values exceeding $3.1 million. The company's core competencies in pharmaceutical supply, medical equipment distribution, and healthcare logistics make it well-positioned to deliver naloxone hydrochloride—a critical medication used in opioid overdose response—to support federal agency operational requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/29/25 |